NUCLEOSIDES AND NUCLEOTIDES .141. CHEMICAL-STABILITY OF A NEW ANTITUMOR NUCLEOSIDE, O-2'-DEOXY-1-BETA-D-ARABINO-PENTOFURANOSYLCYTOSINE IN ALKALINE-MEDIUM - FORMATION OF YANO-2'-DEOXY-1-BETA-D-RIBO-PENTOFURANOSYLCYTOSINE AND ITS ANTITUMOR-ACTIVITY

Citation
A. Azuma et al., NUCLEOSIDES AND NUCLEOTIDES .141. CHEMICAL-STABILITY OF A NEW ANTITUMOR NUCLEOSIDE, O-2'-DEOXY-1-BETA-D-ARABINO-PENTOFURANOSYLCYTOSINE IN ALKALINE-MEDIUM - FORMATION OF YANO-2'-DEOXY-1-BETA-D-RIBO-PENTOFURANOSYLCYTOSINE AND ITS ANTITUMOR-ACTIVITY, Journal of medicinal chemistry, 38(17), 1995, pp. 3391-3397
Citations number
13
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
38
Issue
17
Year of publication
1995
Pages
3391 - 3397
Database
ISI
SICI code
0022-2623(1995)38:17<3391:NAN.CO>2.0.ZU;2-5
Abstract
We have designed o-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (C NDAC) as a potential mechanism-based DNA-strand-breaking nucleoside, w hich showed potent tumor cell growth inhibitory activity against vario us human tumor cell lines in vitro and in vive. When measuring the pK( a) of the 2'alpha-proton of CNDAC, we found that CNDAC epimerized to 2 '-C-cyano-2'-deoxy-1 -beta-D-ribo-pentofuranosylcytosine (CNDC) with c oncomitant degradation of both CNDAC and CNDC to cytosine and anhydro- 2-C-cyano-2-deoxy-D-erythro-pent-1-enitol. Kinetic analysis of these r eactions showed that abstraction of the acidic 2'-proton of CNDAC and CNDC initiated the reactions, which quickly reached an equilibrium. In the equilibrium, a concentration ratio of CNDAC and CNDC was about 3: 5. Concomitant degradation of these nucleosides was found to be rather slow. Deuterium incorporation experiments with CNDAC in a D2O buffer suggested the mechanism of the beta-elimination reactions is an E1cB t ype. These epimerization and degradation reactions were found even in neutral conditions (pH 7.5) and also occurred in RPMI 1640 cell cultur e medium. The discovery of which nucleoside possesses the predominate tumor cell growth inhibitory activity was important. While both nucleo sides showed potent tumor cell growth inhibitory activity against thre e human tumor cell lines (colon carcinoma WiDr, small cell lung carcin oma SBC-5, and stomach carcinoma MKN-74 cells) in 48 h of incubation, in 20 min of incubation, CNDAC was 11-50 times more effective than CND C. In vivo antileukemic activity of these nucleosides against a mouse P388 model, CNDAC was obviously superior to CNDC. Therefore, tumor cel l growth inhibitory activity of CNDC could be related to the quantity of CNDAC produced in the tumor cells by the equilibrium initiated by t he abstraction of the acidic 2'-proton of CNDC.